Solid‐Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202424118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Baoli Ding und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang U…. Hauptthemen laut MEDLINE: Solid-Phase Synthesis Techniques, Small Molecule Libraries, Drug Discovery. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Phenotypic screening offers an effective path for discovering protein degraders, particularly targeting proteins that are poorly characterized or lack sufficient ligand‐binding information. Nonetheless, phenotypic protein degrader discovery (PPDD) faces practical hurdles, such as synthetic complexity in generating chemically diverse libraries and difficulties in reliably identifying degradation‐driven phenotypes in direct‐to‐biology (D2B) assays. In response to these challenges, we developed an integrated PPDD platform that combines optimized solid‐phase parallel synthesis with a robust D2B screening workflow. Leveraging photocleavable linkers and versatile synthetic strategies, this platform facilitates rapid generation of chemically diverse, ready‐to‐screen bifunctional molecule libraries requiring minimal purification. As a proof of concept, we synthesized and phenotypically screened 130 cereblon‐recruiting molecules, leading to several promising protein degradation‐dependent hits. Subsequent hit optimization and target identification validated compound 12–60 as a structurally novel GSPT1 degrader with compelling cellular activity. Overall, our integrated platform represents an efficient and practical toolkit for PPDD, establishing a versatile foundation to accelerate future campaigns and expand the degradable proteome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P.R. China.
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, 310018, P.R. China.
- Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Hangzhou, 310058, P.R. China.
- School of Medicine, Hangzhou City University, Hangzhou, 310015, P.R. China.
- Center for Drug Safety Evaluation and Research, Zhejiang University, Hangzhou, 310058, P.R. China.
ORCID-Profile: Cheng-Liang Zhu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Ding, B., Hu, J., Zhang, R., Shou, B., Chen, M., Jiang, L., Yuan, M., Yang, B., He, Q., Cao, J., & Zhu, C. L. (2025). Solid‐Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202424118
Vancouver
Ding B, Hu J, Zhang R, Shou B, Chen M, Jiang L, et al. Solid‐Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202424118
BibTeX
@article{Ding2025,
author = {Ding, Baoli and Hu, Jiawen and Zhang, Rongtian and Shou, Binyan and Chen, Mengdie and Jiang, Li and Yuan, Meng and Yang, Bo and He, Qiaojun and Cao, Ji and Zhu, Cheng-Liang},
title = {Solid‐Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202424118}
}
EUVIMED